Biblio Discovery — Demo Discovery Service

9 results for "Alper Coskun"

Showing 1–9 · 4.14 seconds · RSS

  1. Journal Article

    Evaluation of Perioperative Clinical Parameters and Quality of Life in Patients Undergoing Radical Perineal or Retropubic Prostatectomy: A Prospective Randomized Study

    Utku Can; Alper Coskun

    The New Journal of Urology, Vol. 19 No. 1 · 2024 · English · DOAJ

    Objective: The objective of study is to investigate the effects of radical retropubic and perineal prostatectomy methods in addition to the effect of pelvic lymph node dissection on perioperative morbidities, oncological outcomes and 1-year quality of life in patients with clinically local stage…

  2. Journal Article Full text

    Efficacy of magnetic resonance imaging for diagnosis of penile fracture: A controlled study

    Erkin Saglam; Fatih Tarhan; Mustafa B. Hamarat et al.

    Investigative and Clinical Urology, Vol. 58 No. 4 · 2017 · English · DOAJ Scopus

    Purpose: To evaluate the diagnostic value of magnetic resonance imaging (MRI) in patients with suspected penile fracture. Materials and Methods: A total of 122 patients admitted to our inpatient clinic with a suspicion of penile fracture following a recent history of penile trauma and who underwent…

  3. Journal Article

    The effect of HbA1C variability on the development and progression of diabetic nephropathy

    Alper Coskun; Aslihan Calim; Emre Sedar Saygili et al.

    Frontiers in Clinical Diabetes and Healthcare, Vol. 6 · 2025 · English · DOAJ Scopus

    ObjectiveDiabetes mellitus (DM) is a prevalent chronic disease that can lead to severe microvascular complications. Among these, diabetic nephropathy (DN) remains a leading cause of end-stage renal disease worldwide. Glycemic variability, reflecting fluctuations in blood glucose, has been suggested…

  4. Journal Article

    Prognostic Impact of Blood Transfusions During Nivolumab Therapy in Metastatic Non-Small Cell Lung Cancer

    Alper Coskun; Eyyup Cavdar; Ece Tolgay et al.

    Technology in Cancer Research & Treatment, Vol. 25 · 2026 · English · DOAJ Scopus

    Introduction Immune checkpoint inhibitors (ICIs) are standard therapy for metastatic non-small cell lung cancer (NSCLC). Blood transfusions, particularly erythrocyte suspension (ES) transfusions, may induce immunomodulatory effects and potentially influence cancer outcomes. This study investigated…

  5. Journal Article Full text

    Survival Outcomes in Patients with Squamous Cell Carcinoma of the Urinary Bladder: A Propensity Score-Matched Analysis

    Alper Coskun; Ahmet Bilgehan Sahin; Selva Kabul et al.

    Current Oncology, Vol. 32 No. 7 · 2025 · English · DOAJ Scopus

    Background and Objective: Bladder cancer (BC) is the ninth most common malignancy worldwide. Squamous cell carcinoma (SqCC), a rare histological variant, accounts for approximately 2–5% of all BC cases. Compared to urothelial carcinoma, the predominant subtype, research on SqCC remains limited and…

  6. Journal Article Full text

    Prediction of Cardiac Arrhythmias in Cancer Patients Treated with Immune Checkpoint Inhibitors Using Electrocardiogram

    Alper Coskun; Ece Celebi Coskun; Ahmet Bilgehan Sahin et al.

    Diagnostics, Vol. 15 No. 10 · 2025 · English · DOAJ Scopus

    Background/Objectives: Immune checkpoint inhibitor (ICI)-associated cardiovascular adverse events are relatively uncommon; they can be life-threatening, particularly when involving malignant ventricular arrhythmias. Electrocardiographic markers such as P-wave dispersion (PWD), QT dispersion (QTd)…

  7. Journal Article

    Left ventricular global longitudinal strain in patients treated with immune checkpoint inhibitors

    Ece Celebi Coskun; Alper Coskun; Ahmet Bilgehan Sahin et al.

    Frontiers in Oncology, Vol. 14 · 2024 · English · DOAJ Scopus

    BackgroundImmune checkpoint inhibitors (ICI) are generally associated with rare cardiac side effects, yet instances like myocarditis can be fatal. Therefore, detecting and managing left ventricular dysfunction early in ICI therapy is vital.ObjectivesThis study aims to evaluate whether left…

  8. Journal Article

    Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)

    Nargiz Majidova; Sendag Yaslıkaya; Maral Martin Mıldanoglu et al.

    The Turkish Journal of Gastroenterology, Vol. 36 No. 5 · 2025 · English · DOAJ Scopus

    Background/Aims: The treatment of hepatocellular carcinoma (HCC), which accounts for 90% of all liver cancers, is highly varied. The use of second-line treatments following progression on first-line atezolizumab and bevacizumab (Atez/Bev) for advanced HCC remains controversial. The aim of this…

  9. Journal Article

    Real-world comparison of doxorubicin–ifosfamide versus gemcitabine–docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study

    Salih Tunbekici; Gokhan Sahin; Haydar Cagatay Yuksel et al.

    Discover Oncology, Vol. 16 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background Uterine leiomyosarcoma is a rare and aggressive malignancy with limited responsiveness to standard therapies. We conducted a real-world, multicenter study to compare the clinical efficacy and safety of two commonly used first-line chemotherapy regimens—doxorubicin–ifosfamide and…